Supplements and GLP-1 medications: what to know

If you're on semaglutide or tirzepatide, you've probably noticed two things: you eat less than you used to, and the internet has a lot of opinions about what supplements you should add. Some of those opinions are grounded in real research on nutrient gaps. Others — looking at you, "nature's Ozempic" — are marketing wearing a lab coat.

This guide walks through what the research actually says: which nutrients deserve attention when meals shrink, which supplement combinations raise flags, and one absorption detail that matters if your GLP-1 is a tablet. It is not medical advice, and decisions about prescription medications belong with your prescriber — but you'll leave with better questions to bring them.

Why eating less changes the supplement question

GLP-1 receptor agonists reduce appetite, and that's much of the point. But reviews of GLP-1 users find that total energy intake can drop steeply — with reductions estimated at up to 40% — which makes it genuinely difficult to cover everyday vitamin, mineral, and protein needs from food alone (Current Developments in Nutrition, 2025). GI side effects such as nausea, vomiting, or constipation, plus drinking less fluid overall, can widen the gap further.

This concern is now mainstream. In 2025, four professional organizations — the American College of Lifestyle Medicine, American Society for Nutrition, Obesity Medicine Association, and The Obesity Society — jointly published a clinical advisory on nutritional priorities during GLP-1 therapy. Their list includes a baseline nutrition assessment, management of GI side effects, prevention of micronutrient shortfalls, and adequate protein with strength training to preserve lean mass (The Obesity Society).

Researchers have also started asking what GLP-1 care can borrow from bariatric surgery, where decades of experience with much smaller food intake produced structured monitoring and supplementation protocols. A 2026 commentary in the International Journal of Obesity argues that nutrition "must no longer remain a missing pillar" of medication-assisted weight management and proposes routine dietary review and lab monitoring modeled on bariatric follow-up (Spreckley et al., IJO).

Important nuance before we go nutrient by nutrient: the evidence so far mostly shows intake falling below recommendations, not the medications directly stripping nutrients from the body. That's a meaningful difference — it means food-first strategies and targeted checks, not automatic mega-stacks.

The nutrients researchers are watching

Protein and muscle preservation

When weight comes off quickly, some of it is lean muscle — and protein intake is one of the levers researchers focus on for supporting the maintenance of muscle mass during weight loss. A 2025 review in Nutrients found that GLP-1 users frequently fall short of the protein intakes discussed in the literature for preserving lean body mass, cited there as roughly 1.2–2.0 g per kilogram of body weight per day (Nutrients, 2025). The IJO commentary proposes ranges borrowed from bariatric care — about 0.8–1.6 g/kg/day, or 80–120 g/day in absolute terms — while acknowledging there are no prospective studies yet pinning down an optimal number for GLP-1 users specifically (IJO).

Two practical takeaways survive the hedging. First, the joint advisory pairs protein with resistance training — the two work together, and neither substitutes for the other (The Obesity Society). Second, because portion sizes are small, many people find it easier to put protein first on the plate. Whether a protein powder makes sense for you — and how much — is a good question for a registered dietitian, who can work from your actual intake rather than a generic target.

Vitamin B12

B12 shows up on nearly every proposed monitoring list for GLP-1 users, and the reasoning is mostly preventive. Smaller meals often mean less meat, fish, dairy, and eggs — the main food sources of B12 — and the IJO commentary includes B12 among the nutrients at risk from reduced dietary variety (IJO). There's a second, less obvious reason: many people on GLP-1s for type 2 diabetes also take metformin, and the NIH Office of Dietary Supplements notes that metformin may reduce B12 absorption and lower blood levels over time (NIH ODS).

Worth knowing: short-term studies haven't consistently found B12 deficiency developing in GLP-1 users, so this is a "check, don't assume" nutrient. A simple blood test settles the question far better than guessing in either direction.

Vitamin D

Vitamin D is harder to get from a shrinking diet because so few foods contain much of it. In one analysis reviewed in Nutrients, vitamin D was the most common deficiency to develop within 12 months of starting GLP-1 therapy, affecting 13.6% of patients studied (Nutrients, 2025). Cross-sectional intake data paint a similar picture: average vitamin D intake among GLP-1 users landed around one-fifth of recommendations, with calcium and iron also commonly below target (Current Developments in Nutrition, 2025).

Vitamin D plays a role in normal bone maintenance — relevant during rapid weight loss, when bone density is also under pressure. The NIH ODS fact sheet covers food sources, sun exposure, and safe upper limits (NIH ODS); your clinician can check your level and tell you whether supplementation makes sense for you.

Fiber — an attention area with a caveat

Fiber intake among GLP-1 users frequently falls below recommendations (Current Developments in Nutrition, 2025), and constipation is one of the most common side effects people report. The IJO commentary suggests increasing fiber and fluid intake as part of managing GI symptoms (IJO). So far, so straightforward: vegetables, fruit, legumes, and whole grains remain the food-first answer.

The caveat arrives with fiber supplements. Gel-forming fibers like psyllium increase the viscosity of stomach contents, and some studies suggest this can slow gastric emptying — though findings are mixed, and at least one controlled study found no measurable delay (Eur J Clin Nutr; IJMS, 2026). Here's why that matters: GLP-1 medications already slow gastric emptying. Layering a viscous fiber on top may compound fullness, bloating, or nausea for some people. That doesn't make psyllium off-limits — it makes dose, timing, and your current side-effect picture worth discussing with your prescriber or dietitian before you add it, and worth watching if you already have one in your routine.

Hydration and electrolytes

Two things work against fluid intake on GLP-1s: some users report blunted thirst alongside blunted appetite, and GI side effects like vomiting or diarrhea can drain both fluids and electrolytes (Current Developments in Nutrition, 2025; Healthline). Because thirst may not be a reliable signal, commonly suggested habits include drinking on a schedule rather than by feel, aiming for roughly 2–3 liters of fluid daily as a general adult reference point, and leaning on hydrating foods like soups and fruit (GoodRx).

Electrolyte products deserve a measured take. Most people meeting food needs don't require them daily, but during a stretch of vomiting or diarrhea, replacing fluids and electrolytes together may support normal fluid balance. If you have kidney or heart disease, run any electrolyte supplement past your healthcare team first — those conditions change how your body handles sodium and potassium (GoodRx).

The "nature's Ozempic" problem

Berberine — a compound found in plants like barberry and goldenseal — became a social media phenomenon under the nickname "nature's Ozempic." The nickname oversells it. NCCIH's review of the evidence notes that while a 2022 analysis of 18 studies found decreases in weight and BMI among berberine takers, many of the studies carried a high risk of bias, and the evidence is not conclusive (NCCIH). UCLA Health's assessment is blunter: the Ozempic comparison appears driven more by marketing than by science (UCLA Health).

Here's the part that matters for anyone already on a GLP-1: berberine's best-documented activity is glucose-lowering. Clinical research in type 2 diabetes has repeatedly found blood-glucose-lowering effects, with some studies comparing its effect size to metformin (UCLA Health). That's exactly why stacking it on a GLP-1 raises flags rather than adding benefit:

• Glucose-lowering on top of glucose-lowering. Your prescription already lowers blood glucose. Adding a second agent with the same direction of effect creates a combination that hasn't been studied together — and the stakes rise further for anyone also using insulin or a sulfonylurea.
• GI load on top of GI load. Berberine is known for digestive side effects; nausea, constipation, and stomach upset are also the most common GLP-1 side effects. The overlap can make it hard to tell what's causing what — which matters, because side-effect patterns are part of how prescribers manage these medications.
• No demonstrated upside for the stack. There is no clinical evidence that berberine adds anything to GLP-1 therapy. The "natural alternative" pitch was never designed for people already on the medication.

Our interaction watch-list marks the berberine + GLP-1 combination as one to avoid, and we don't soften that flag. If berberine interests you anyway, that's a conversation to have with your prescriber — with your glucose readings on the table — not a quiet addition to the cabinet.

The same logic extends, more gently, to other supplements marketed for blood sugar (cinnamon extracts, chromium, gymnema, and friends): anything sold on a glucose-lowering promise deserves a prescriber conversation before it joins a GLP-1 regimen (NCCIH).

If your GLP-1 is a tablet: the Rybelsus timing note

Injectable semaglutide and tirzepatide don't depend on your stomach for absorption. Rybelsus — oral semaglutide — does, and only a small fraction of each tablet is absorbed under the best conditions. Its labeling describes taking the tablet on an empty stomach with no more than 4 ounces of plain water, then waiting at least 30 minutes before eating, drinking anything else, or taking other oral medications, because food, beverages, and other oral products can reduce how much semaglutide gets absorbed (Rybelsus FAQ; Mayo Clinic).

Supplements swallowed in that window — a multivitamin with breakfast, a fiber drink, morning electrolytes — fall under the same consideration. This isn't a reason to change anything on your own; it's a reason to ask your pharmacist to help you map your supplement timing around the routine your prescriber set. Pharmacists solve exactly this kind of scheduling puzzle all day.

What about a multivitamin?

Given everything above, a daily multivitamin sounds like the obvious move — and some researchers lean that way. The Current Developments in Nutrition review suggests a "physiologically dosed" multivitamin-mineral supplement is reasonable to consider while intake is reduced, and the IJO commentary proposes routine use of a complete multivitamin as an interim strategy borrowed from bariatric care (CDN, 2025; IJO). Both also concede the evidence isn't strong enough yet for formal recommendations.

A sensible reading: a standard once-daily multivitamin is a low-stakes insurance layer worth raising with your clinician, while high-dose single nutrients are a different conversation that should follow lab work, not precede it.

Questions worth bringing to your prescriber

A supplement check is most useful as preparation. These five questions cover the ground this article mapped:

• Should we check my B12, vitamin D, or iron levels — now or at a future visit?
• How much protein should I personally aim for, and would a referral to a dietitian help?
• I'm considering [specific supplement] — does anything about it overlap with my medication's effects?
• My fiber or fluid intake has dropped — what do you suggest before I add supplements?
• (If on Rybelsus) When in my day should oral supplements go, given the 30-minute window?

The bottom line

Smaller meals make nutrition a planning exercise, and the research points to a consistent short list: protein for supporting muscle maintenance, B12 and vitamin D worth checking, fiber and fluids worth tracking, and electrolytes situationally. On the supplement side, the loudest product marketed at GLP-1 users — berberine, the so-called "nature's Ozempic" — is the one whose stacking logic holds up worst. Check your combinations, bring the results to your prescriber, and let labs — not marketing — decide what earns a spot in your routine.

This article is for education only and is not medical advice. Never start, stop, or change a prescription medication or supplement routine without talking with your prescriber.